Delivery of glycoside hydrolases to combat bacterial biofilms
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-FDP-019
- By: THORN, Chelsea (University of South Australia, School of Pharmacy and Medical Science)
- Co-author(s): Chelsea Renee Thorn: School of Pharmacy and Medical Science and ARC Centre for Excellence in Bio-Nano Science and Technology, University of South Australia, Adelaide, Australia
Clive A. Prestidge: School of Pharmacy and Medical Science and ARC Centre for Excellence in Bio-Nano Science and Technology, University of South Australia, Adelaide, Australia
Ben J. Boyd: Drug Delivery Disposition and Dynamics, and ARC Centre for Excellence in Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Melbourne, Australia
Nicky Thomas: School of Pharmacy and Medical Science and ARC Centre for Excellence in Bio-Nano Science and Technology, University of South Australia, Adelaide, Australia - Abstract:
Background
The morbidity resulting from chronic wounds is dramatically increasing with 90% of wounds being related to antibiotic-tolerant biofilm infections [1]. Glycoside hydrolases (e.g. alginate lyase), are potent, novel therapies to disrupt biofilms, and increase the susceptibility of residing bacteria to antibiotics [3]. However, the clinical.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023